The magic continues for the iPS strategy.
Pei
Duanqing
D
Stem Cell and Cancer Biology Group, Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Chinese Academy of Sciences, Guangzhou, China. pei_duanqing@gibh.ac.cn
D000755:Anemia, Sickle Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000096:biosynthesis* / Q000235:genetics; D054337:Cell Dedifferentiation / Q000502:physiology*; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000166:cytology / Q000502:physiology*; D006801:Humans; D051379:Mice; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000502:physiology* / Q000637:transplantation; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis* / Q000235:genetics; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics
D000952:Antigens, Polyomavirus Transforming; D016271:Proto-Oncogene Proteins c-myc; D014157:Transcription Factors